Danske Bank share buy-back programme: transactions in week 25
| Company announcement Company announcement No. 39/2018 | Group Communications Holmens Kanal 2 – 12 DK-1092 København K Tel. +45 45 14 56 95 25 June 2018 |
Danske Bank share buy-back programme: transactions in week 25
On 2 February 2018, Danske Bank A/S announced a share buy-back programme. The programme is being carried out under Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (the “Market Abuse Regulation”). The share buy-back for a total of DKK 10 billion, with a maximum of 85 million shares, will be made in the period from 5 February 2018 to 1 February 2019, at the latest.
The following transactions were made under the share buy-back programme in week 25:
| Number of shares | VWAP DKK | Gross value DKK | |
| Total, latest announcement | 16,084,000 | 3,663,855,900 | |
| 18 June 2018 | 200,000 | 214.66 | 42,932,000 |
| 19 June 2018 | 190,000 | 210.54 | 40,002,600 |
| 20 June 2018 | 200,000 | 208.85 | 41,770,000 |
| 21 June 2018 | 220,000 | 207.50 | 45,650,000 |
| 22 June 2018 | 200,000 | 207.63 | 41,526,000 |
| Total accumulated over week 25 | 1,010,000 | 211,880,600 | |
| Total accumulated during the share buyback programme | 17,094,000 | 3,875,736,500 |
With the transactions stated above, Danske Bank A/S holds a total of 19,875,468 own shares, excluding investments made on behalf of customers, or 2.22% of Danske Bank A/S share capital.
We enclose share buy-back transactions data in detailed and aggregated form provided in accordance with the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016.
Danske Bank
Contact: Kenni Leth, Group Press Officer, tel. +45 45 14 14 00
Attachments
© 2018 GlobeNewswire, Inc. All Rights Reserved.
Moderna (Nasdaq: MRNA) Announces Supply Agreement with the Ministry of Public Health to Supply Qatar with mRNA Vaccine Against COVID-19 (mRNA-1273)
